
Self defense company AXON (NASDAQ: AXON) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 35.3% year on year to $904.4 million. Its non-GAAP profit of $1.88 per share was 2% above analysts’ consensus estimates.
Is now the time to buy AXON? Find out in our full research report (it’s free for active Edge members).
Axon (AXON) Q2 CY2026 Highlights:
- Revenue: $904.4 million vs analyst estimates of $875.9 million (35.3% year-on-year growth, 3.3% beat)
- Adjusted EPS: $1.88 vs analyst estimates of $1.84 (2% beat)
- Adjusted EBITDA: $242 million vs analyst estimates of $220.4 million (26.8% margin, 9.8% beat)
- Operating Margin: 5.2%, up from -0.2% in the same quarter last year
- Annual Recurring Revenue: $1.64 billion (38.5% year-on-year growth, beat)
- Market Capitalization: $49.13 billion
StockStory’s Take
Axon's second quarter results surpassed Wall Street expectations on both revenue and adjusted earnings, but the market reacted negatively, reflecting investor concerns about profitability and the trajectory of margins. Management attributed strong performance to broad-based demand for Axon’s ecosystem, with notable growth in international markets and the rapid scaling of its counter-drone and AI-enabled software segments. CEO Rick Smith pointed to the company’s expanding role in public safety technology, highlighting how the integration of sensors, AI, and connected devices is driving customer wins and reinforcing Axon’s position as a trusted provider.
Looking forward, Axon’s outlook centers on the continued rollout of new software offerings, increased adoption of the AI Era Plan, and the scaling of recent acquisitions such as Dedrone and Carbyne. Management anticipates sustained growth across U.S., international, and enterprise markets, but cautioned that investments in inventory and rising component costs—especially for memory—will weigh on margins in the near term. CFO Brittany Bagley emphasized the importance of balancing innovation and operational discipline, stating, “We continue to see strong demand across customer markets and expect the business to continue to scale.”
Key Insights from Management’s Remarks
Management identified rapid expansion in software contributions, strong international traction, and the success of new product categories as central to Axon’s quarter.
- Software ecosystem broadens revenue base: Over a third of Axon’s software revenue now comes from offerings beyond its core Evidence platform, including real-time operations, productivity tools, and counter-drone software, with the AI Era Plan growing nearly 700% year over year.
- Dedrone and counter-drone momentum: Dedrone, Axon’s counter-drone business, has rapidly surpassed $100 million in quarterly revenue, driven by deployments at major events like the World Cup and growing demand from federal, enterprise, and international customers facing heightened drone-related security concerns.
- International markets accelerating adoption: International bookings tripled year over year, with several large deals for TASER 10 and AI-powered solutions. Management noted that some international customers are adopting new offerings faster than U.S. counterparts, particularly in the Middle East and Europe.
- Body camera win-backs and product cycles: Axon is regaining customers who previously chose other vendors for body cameras, citing reliability and ecosystem integration as key factors. Shipments are expected to rise 20%-30% sequentially next quarter, reflecting both renewals and new wins.
- Platform and hardware expansion: Growth in platform solutions and connected devices—such as Outpost and Lightpost—reflects expanding use cases across municipal, enterprise, and federal customers. These products are benefiting from customer demand for privacy, auditability, and integrated workflows.
Drivers of Future Performance
Axon’s guidance is driven by expanding adoption of its AI and software products, continued international momentum, and ongoing investment in new hardware solutions, though margin pressures are expected from inventory and component costs.
- AI and software adoption: Management expects continued growth from AI-powered offerings like the AI Era Plan and Draft One, as well as increased penetration of productivity and operational tools. These software products are seen as key to expanding annual recurring revenue and deepening customer engagement across markets.
- Scaling new businesses and acquisitions: Dedrone and Carbyne are positioned to drive incremental growth, especially as counter-drone regulation expands and integrated solutions like Axon 911 gain traction. Management highlighted the strategic importance of attaching software subscriptions to hardware deployments, creating long-term revenue streams.
- Margin headwinds from investments: While top-line growth is forecast to remain strong, management cautioned that increased inventory investments and rising component costs—particularly for memory—will pressure margins in the near term. Efforts to moderate inventory build and achieve operational leverage are expected to support margin recovery later in the year.
Catalysts in Upcoming Quarters
Looking ahead, the StockStory team will be monitoring (1) the pace of adoption for AI-driven software across both U.S. and international markets, (2) margin recovery as inventory investments moderate and component costs stabilize, and (3) the success of Dedrone and Axon 911 in winning large federal and enterprise contracts. Execution on integrating software with hardware deployments and maintaining customer trust in sensitive areas like data privacy will also be critical signposts.
Axon currently trades at $582.51, down from $609.49 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).
High Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.